Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study.
Royal V, Leung N, Troyanov S, Nasr SH, Écotière L, LeBlanc R, Adam BA, Angioi A, Alexander MP, Asunis AM, Barreca A, Bianco P, Cohen C, Drosou ME, Fatima H, Fenoglio R, Gougeon F, Goujon JM, Herrera GA, Knebelmann B, Lepori N, Maletta F, Manso R, Motwani SS, Pani A, Rabant M, Rennke HG, Rocatello D, Rosenblum F, Sanders PW, Santos A, Soto K, Sis B, Touchard G, Venner CP, Bridoux F. Royal V, et al. Among authors: barreca a. Blood. 2020 May 21;135(21):1833-1846. doi: 10.1182/blood.2019003807. Blood. 2020. PMID: 32160635 Free PMC article.
IgG4-related kidney disease: the effects of a Rituximab-based immunosuppressive therapy.
Quattrocchio G, Barreca A, Demarchi A, Solfietti L, Beltrame G, Fenoglio R, Ferro M, Mesiano P, Murgia S, Del Vecchio G, Massara C, Rollino C, Roccatello D. Quattrocchio G, et al. Among authors: barreca a. Oncotarget. 2018 Apr 20;9(30):21337-21347. doi: 10.18632/oncotarget.25095. eCollection 2018 Apr 20. Oncotarget. 2018. PMID: 29765543 Free PMC article.
Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results.
Mella A, Gallo E, Messina M, Caorsi C, Amoroso A, Gontero P, Verri A, Maletta F, Barreca A, Fop F, Biancone L. Mella A, et al. Among authors: barreca a. World J Transplant. 2018 Sep 10;8(5):178-187. doi: 10.5500/wjt.v8.i5.178. World J Transplant. 2018. PMID: 30211026 Free PMC article.
Cryoglobulinemic glomerulonephritis: clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy.
Rossi D, Sciascia S, Fenoglio R, Ferro M, Baldovino S, Kamgaing J, Ventrella F, Kalikatzaros I, Viziello L, Solfietti L, Barreca A, Roccatello D. Rossi D, et al. Among authors: barreca a. Minerva Med. 2021 Apr;112(2):162-174. doi: 10.23736/S0026-4806.20.07076-7. Epub 2020 Nov 16. Minerva Med. 2021. PMID: 33198442 Review.
The Challenging Management of Cancer: An Immunonephrologist's Perspective.
Fenoglio R, Roccatello D, De Simone E, Del Vecchio G, Ferro M, Quattrocchio G, Barreca A, Sciascia S. Fenoglio R, et al. Among authors: barreca a. Kidney Blood Press Res. 2021;46(1):114-120. doi: 10.1159/000511256. Epub 2020 Dec 16. Kidney Blood Press Res. 2021. PMID: 33326976 Free article.
207 results